Intellectual Property Challenges in the Biotechnology Industry

Introduction

Figure 1. Myriad Genetics.Inc logo.Source: https://www.tradingview.com/symbols/NASDAQ-MYGN/technicals/

The IPR System

The Biotech Sector

Case Study: Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al.

Discussion

Non-patentability stalling R&D investment

Table 1. Summary of arguments against and in favour of gene patents.

Striking the balance

Conclusion

References

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store